Literature DB >> 17504820

Caspase 7 influences susceptibility to rheumatoid arthritis.

J R García-Lozano1, B Torres, O Fernández, G Orozco, A Alvarez-Márquez, A García, M A González-Gay, A García, A Núñez-Roldán, J Martín, M F González-Escribano.   

Abstract

OBJECTIVE: The aim of this study was to investigate the possible role of the caspase 7 (CASP7) in susceptibility to rheumatoid arthritis (RA).
METHODS: Genotyping of three single nucleotide polymorphisms (SNPs) of the CASP7 gene: rs11593766 (G/ T), rs2227310 (C/G) and rs2227309 (G/A) was performed in a total of 906 RA patients and 528 matched healthy controls using TaqMan assays. All the subjects were of Spanish Caucasian origin. A relative quantification of mRNA encoding the non-functional variant of procaspase 7 (isoform beta) vs functional isoforms was performed in total RNA from 32 healthy individuals using real-time PCR.
RESULTS: Only the rs2227309 SNP was found to be associated with susceptibility to RA. Frequency of the G allele was significantly higher among RA patients [overall frequency of the G allele 74.0% in cases vs 68.4% in controls, P = 0.001, Odds ratio (OR) = 1.32, 95% Confidence intervals (95% CI) 1.11-1.56] and a higher frequency of GG homozygous individuals was found in the RA patient group (overall frequency of GG genotype 56.0% in cases and 46.4% in controls, P = 0.0005, OR = 1.47, 95%CI 1.18-1.83). A statistically significant deviation was observed to compare the relative expression of the procaspase 7 isoform beta in samples from individuals stratified according their rs2227309 genotypes (AA + AG: 1.36 +/- 0.55, n = 19, vs GG: 2.35 +/- 0.74, n = 13; P = 0.0002).
CONCLUSION: Our results support involvement of the CASP7 gene in the susceptibility to RA. The higher production of the no functional variant of CASP7 by individuals with a particular genotype could be the basis of this association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504820     DOI: 10.1093/rheumatology/kem096

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

1.  A Large-scale genetic association study of esophageal adenocarcinoma risk.

Authors:  Chen-Yu Liu; Michael C Wu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Rihong Zhai; Zhaoxi Wang; Li Su; Rebecca S Heist; Matthew H Kulke; Xihong Lin; Geoffrey Liu; David C Christiani
Journal:  Carcinogenesis       Date:  2010-05-07       Impact factor: 4.944

2.  RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection.

Authors:  Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Su Jeong Lee; Byung Woog Kang; Joon Ho Moon; Jae Yong Park; Seong Woo Jeon; Han-Ik Bae; Gyu Seog Choi; Soo-Han Jun
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-22       Impact factor: 4.553

3.  Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases.

Authors:  José Raúl García-Lozano; Cristina Abad; Ana Escalera; Belén Torres; Olga Fernández; Alicia García; Julio Sánchez-Román; José-Mario Sabio; Norberto Ortego-Centeno; Enrique Raya-Alvarez; Antonio Núñez-Roldán; Javier Martín; María Francisca González-Escribano
Journal:  Hum Genet       Date:  2010-06-12       Impact factor: 4.132

Review 4.  Current aspects of vitiligo genetics.

Authors:  Rafał Czajkowski; Kaja Męcińska-Jundziłł
Journal:  Postepy Dermatol Alergol       Date:  2014-08-22       Impact factor: 1.837

Review 5.  Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci.

Authors:  Changbing Shen; Jing Gao; Yujun Sheng; Jinfa Dou; Fusheng Zhou; Xiaodong Zheng; Randy Ko; Xianfa Tang; Caihong Zhu; Xianyong Yin; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Genet       Date:  2016-02-01       Impact factor: 4.599

6.  MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.

Authors:  Wei Jiang; Nan Bi; Wen-Jue Zhang; Li-Hong Wu; Li-Pin Liu; Yu Men; Jing-Bo Wang; Jun Liang; Zhou-Guang Hui; Zong-Mei Zhou; Lu-Hua Wang
Journal:  Oncotarget       Date:  2016-04-19

7.  Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Tracey M Ferrara; Songtao Ben; Sheri L Riccardi; Joanne B Cole; Katherine Gowan; Paulene J Holland; Dorothy C Bennett; Rosalie M Luiten; Albert Wolkerstorfer; J P Wietze van der Veen; Anke Hartmann; Saskia Eichner; Gerold Schuler; Nanja van Geel; Jo Lambert; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Margaret R Wallace; Wayne T McCormack; Mauro Picardo; Giovanni Leone; Andreas Overbeck; Nanette B Silverberg; Richard A Spritz
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

8.  Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.

Authors:  Meng-Yun Wang; Mei-Ling Zhu; Jing He; Ting-Yan Shi; Qiao-Xin Li; Ya-Nong Wang; Jin Li; Xiao-Yan Zhou; Meng-Hong Sun; Xiao-Feng Wang; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Qing-Yi Wei
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering.

Authors:  Girish Srinivas; Steffen Möller; Jun Wang; Sven Künzel; Detlef Zillikens; John F Baines; Saleh M Ibrahim
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus.

Authors:  William Leonardi; Leeor Zilbermintz; Luisa W Cheng; Josue Zozaya; Sharon H Tran; Jeffrey H Elliott; Kseniya Polukhina; Robert Manasherob; Amy Li; Xiaoli Chi; Dima Gharaibeh; Tara Kenny; Rouzbeh Zamani; Veronica Soloveva; Andrew D Haddow; Farooq Nasar; Sina Bavari; Michael C Bassik; Stanley N Cohen; Anastasia Levitin; Mikhail Martchenko
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.